Activation of c-fos expression in the heart after morphine but not U-50,488H withdrawal

British Journal of Pharmacology

Volumn 138, Issue 4, 2003, Pages 626-633

  González Cuello, Ana ^a   Milanés, M Victoria ^a   Castells, M Teresa ^a   Laorden, M Luisa ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Chromatography; Fos; Heart; Immunohistochemical; Morphine withdrawal; Noradrenaline turnover; U 50,488H withdrawal; Western blot

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; MORPHINE; NALOXONE; NORADRENALIN; NORBINALTORPHIMINE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG IMPLANTATION; DRUG WITHDRAWAL; GENE ACTIVATION; GENE EXPRESSION; HEART; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART VENTRICLE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INJECTION; MALE; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; GENE EXPRESSION REGULATION; HEART; MALE; MORPHINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0037294318     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705093     Document Type: Article

References (36)

1. ANGEL, P. & KARIN, M. (1991). Phorbol ester-inducible genes contain a common Cis element recognized by a TPA-modulated Trans-acting factor. Biochim. Biophys. Acta, 1072, 129-157.
2. BECKMANN, A.M., MATSUMOTO, I. & WILCE, P.A. (1995). Immediate early gene expression during morphine withdrawal. Neuropharmacology, 34, 1183-1189.
3. BERHOW, M.T., RUSSEL, D.S., TERWILLIGER, R.Z., BEITNER-JOHNSON, D., SELF, D.W., LINDSAY, R.M. & NESTLER, E.J. (1995). Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience, 68, 969-979.
4. BLENDY, J.A. & MALDONADO, R. (1998). Genetic analysis of drug addiction: the role of cAMP response element binding protein. J. Mol. Med., 76, 104-110.
5. FRANKEL, P.S., HARLAN, R.E. & GARCIA, M.M. (1999). Chronic administration of morphine alters immediate-early gene expression in the forebrain of postdependent rats. Brain Res., 835, 204-212.
6. FUERTES, G., MILANÉS, M.V., RODRÍGUEZ-GAGO, M., MARÍN, M.T. & LAORDEN, M.L. (2000). Changes in hypothalamic paraventricular nucleus catecholaminergic activity after acute and chronic morphine administration. Eur. J. Pharmacol., 388, 49-56.
7. HANNAN, R.D., STENNARD, F.A. & WEST, A.K. (1993). Expression of c-fos and related genes in the rat heart in response to norepinephrine. J. Mol. Cell. Cardiol., 25, 1137-1148.
8. HANNAN, R.D. & WEST, A.K. (1991). Adrenergic agents, but not triiodo L-thyronine induce c-fos and c-myc expression in the rat heart. Basic. Res. Cardiol., 86, 154-164.
9. HUGHES, P. & DRAGUNOW, M. (1995). Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev., 47, 133-178.
10. KOMURO, I. & YAZAKI, Y. (1993). Control of cardiac expression by mechanical stress. Annu. Rev. Physiol., 55, 55-57.
11. LAORDEN, M.L., CASTELLS, M.T. & MILANÉS, M.V. (2002). Effects of morphine and morphine withdrawal on brainstem neurons innervating hypothalamic nuclei that control the pituitary-adrenocortical axis in rats. Br. J. Pharmacol., 136, 67-75.
12. LAORDEN, M.L., CASTELLS, M.T., MARTINEZ, M.D., MARTINEZ, P.J. & MILANÉS, M.V. (2000a). Activation of c-fos expression in hypothalamic nuclei by μ- and κ-receptor agonists: Correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus. Endocrinology, 241, 1366-1376.
13. 2adrenoceptors. J. Pharmacol. Exp. Ther., 293, 578-584.
14. LAORDEN, M.L. & MILANÉS, M.V. (2000). Effects of U-50,488H and U-50,488H withdrawal on catecholaminergic neurons of the rat hypothalamus. Life Sci., 66, 803-815.
15. LARSEN, T.J., SKAR, R., FROTJOLD, E.K., HAUKANES, K., GREVE, G. & SAETERSDAL, T. (1998). Regional activation of the immediate-early response gene c-fos in infarcted rat hearts. Int. J. Exp. Path., 79, 163-172.
16. MILANÉS, M.V. & LAORDEN, M.L. (1998). Effects of U-50,488H withdrawal on catecholaminergic neurones of the rat ventricle. Br. J. Pharmacol., 124, 1060-1064.
17. 2-adrenoceptors. Eur. J. Pharmacol., 397, 311-318.
18. MILANÉS, M.V., FUENTE, T. & LAORDEN, M.L. (2000). Catecholaminergic activity and 3′,5′-cyclic adenosine monophosphate levels in heart right ventricle after naloxone induced withdrawal. Naunyn-Schmiedeberg's Arch. Pharmacol., 361, 61-66.
19. MILANÉS, M.V., LAORDEN, M.L., CHAPLEUR-CHÂTEAU, M. & BURLET, A. (1998). Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: Correlation with hypothalamic noradrenergic activity and pituitary-adrenal response. J. Pharmacol. Exp. Ther., 285, 700-706.
20. MILANÉS, M.V., MARTINEZ, M.D., GONZÁLEZ-CUELLO, A. & LAORDEN, M.L. (2001). Evidence for a peripheral mechanism in cardiac opioid withdrawal. Naunyn-Schmiedeberg's Arch. Pharmacol., 364, 193-198.
21. MILNER, R.J., CODDINSTON, J.M. & GAMBLE, G.D. (1990). Quaternary naloxone blocks morphine analgesia in spinal but not intact rats. Neurosci. Lett., 114, 259-264.
22. MIZUKAMI, Y. & YOSHIDA, K. (1997). Mitogen-activated prokinase translocates to the nucleus during ischaemia and activated during reperfusion. Biochem. J., 323, 785-790.
23. MORGAN, J.I. & CURRAN, T. (1991). Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Ann. Rev. Neurosci., 14, 421-451.
24. NESTLER, E.J. (1994). Molecular mechanisms of drug addiction. J. Neurosci., 12, 2439-2450.
25. NESTLER, E.J. & AGHAJANIAN, G.K. (1997). Molecular and cellular basis of addiction. Science, 278, 58-63.
26. NESTLER, E.J., HOPE, B.T. & WIDNELL, K.L. (1993). Drug addiction: a model for molecular basis of neural plasticity. Neuron, 11, 995-1006.
27. OGINO, K., CAI, B., GU, A., KOHMOTO, T., YAMAMOTO, N. & BURKHOFF, C. D. (1999). Factors contributing to pressure overload-induced immediate early gene expression in adult rat hearts in vivo. Am. J. Physiol., 277, H380-H387.
28. PARADIS, P., McLELLAN, W.R., BELAGULI, N.S., SCHWART, R.J. & SCHNEIDER, M.D. (1996). Serum response factor mediates AP-1-dependent induction of the skeletal α actin promoter in ventricular myocytes. J. Biol. Chem., 271, 10827-10833.
29. RABADÁN, J.V., MILANÉS, M.V. & LAORDEN, M.L. (1997a). Effects of chronic morphine treatment on catecholamines content and mechanical response in the rat heart. J. Pharmacol. Exp. Ther., 280, 32-37.
30. RABADÁN, J.V., MILANÉS, M.V. & LAORDEN, M.L. (1997b). Effects of acute administration of morphine on right atria catecholamines content and heart rate in chronically morphine-treated rats. Br. J. Anaesth., 78, 439-441.
31. RABADÁN, J.V., MILANÉS, M.V. & LAORDEN, M.L. (1998). Changes in right atria catecholamines content in naïve rats and after naloxone-induced withdrawal. Br. J. Anaesth., 80, 354-359.
32. SHENG, M.E. & GREENBERG, M.E. (1990). The regulation and function of c-fos and other immediate-early genes in the nervous system. Neuron, 4, 477-485.
33. 2+ elevation evoked by k-opioid receptor in rat myocytes. Eur. J. Pharmacol., 4, 323-329.
34. UEYAMA, T., UMEMOTO, S. & SENBA, E. (1996). Immobilization stress induces c-fos and c-jun immediate early genes expression in the heart. Life Sci., 59, 339-347.
35. UEYAMA, T., YOSHIDA, K.I. & SENBA, E. (1999). Emotional stress induced immediate-early gene expression in rat heart via activation of alpha and beta-adrenoceptors. Am. J. Physiol., 277, H1553-H1561.
36. WIECHELMAN, K.J., BRAUND, R.D. & FITZPATRICK, J.D. (1988). Investigation of the bicincinonic acid protein assay: identification of the groups responsible for color formation. Anal. Biochem., 175, 231-237.